Hepatology & Gastro-enterology

09/02/2022

Benefits of Coffe on the liver and other health systems

30/11/2020

30/11/2020

24/05/2020

25/11/2019

25/12/2018

Whether or not HCV patients with active hepatocellular carcinoma should be treated with DAAs remains controversial. This review examines the issues, presenting the current state of knowledge.

17/12/2018

(Apart from Gastroenterology but good point )Clinical trials have shown that patients who have preexisting coronary disease who achieve low diastolic blood pressure (defined as

28/10/2018

Liver transplantation for Metastatic liver !!!!!

New protocol may lead to improved patient outcomes

19/10/2018

How to Approach a Patient With Eosinophilic Esophagitis
Very nice

17/10/2018

Liver diseases in pregnancy

17/10/2018

The prevalence of hepatitis C virus (HCV) infection in women of childbearing age in the United States is approximately 1%. Treatment of HCV infection is contraindicated in pregnancy because of the teratogenicity of the drugs used. There is a 3.8% rate of vertical transmission to infants born to mothers who are viremic at the time of delivery. This rate increases to 25% in mothers coinfected with the human immunodeficiency virus (HIV). Breast-feeding should not be discouraged and the indication for cesarean section should be based on obstetrical reasons. The PCR assay is not sensitive for infants younger than 1 month, and the treatment of HCV is contraindicated in children younger than 3 years because of the potential for neurologic damage. Testing for HCV in children should be delayed until age 18 months.